Document is current
Any future updates will be listed below
-
Authors
Smilowitz, Nathaniel R.
Subashchandran, Varun
Newman, Jonathan
Barfield, Michael E.
Maldonado, Thomas S.
Brosnahan, Shari B.
Yuriditsky, Eugene
Horowitz, James M.
Shah, Binita
Reynolds, Harmony R.
Hochman, Judith S.
Berger, Jeffrey S.
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (K23HL150315, K23 125991, R01HL139909)
National Heart, Lung, and Blood Institute, (R35HL144993)
- License Information
-
More Information
Article History
Received: 9 December 2020
Accepted: 1 February 2021
First Online: 18 February 2021
Competing interests
: Dr. Smilowitz is supported, in part, by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number K23HL150315. Dr. Smilowitz also serves as on the advisory board for Abbott Vascular and as a consultant for Medyria, and reports no conflicts of interest with the current manuscript Dr. Newman is supported, in part, by National Heart and Lung Blood Institute of the National Institute of Health K23 125991. Dr. Horowitz serves on clinical trial steering committees and as a consultant for Inari Medical and Penumbra. Dr. Shah is supported in part by the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development (iK2CX001074) and NIH/NHLBI (R01HL146206). Dr. Shah also serves as on the advisory board for Philips Volcano and Radux Devices and as a consultant for Terumo Medical, and reports no conflicts of interest with the current manuscript. Dr. Reynolds has received in kind support for unrelated research from Abbott Vascular, Siemens, and BioTelemetry Inc. Dr. Berger is funded, in part, by the National Heart and Lung Blood Institute of the National Institute of Health (R01HL139909 and R35HL144993). The remaining authors have no disclosures to report.
